文献速递主动脉疾病

Endurant支架系统EVAR的初始与5年随访费用分析

Index and follow-up costs of endovascular abdominal aortic aneurysm repair from the Endurant Stent Graft System Post Approval Study (ENGAGE PAS).
PubMed 文献 · J Vasc Surg · 2020-01-19

基于ENGAGE PAS研究178例患者,分析EVAR初始及5年随访费用:初始平均住院费用45304美元,手术室耗材占50%;随访再入院多为非动脉瘤相关,但动脉瘤相关再入院费用中位数更高(13119美元 vs 6609美元);门诊随访年人均报销657美元。

要点

  • EVAR初始费用主要来自手术室耗材(占50%,人均22849美元)。
  • 再入院仅14%为动脉瘤相关,但动脉瘤相关住院费用中位数更高(13119美元 vs 6609美元)。
  • 门诊随访影像年人均报销550美元,办公室访视107美元,合计657美元。

核心结论

  • EVAR初始费用主要由手术室耗材驱动,包括移植物组件。
  • 后续再入院大多非动脉瘤相关,但动脉瘤相关住院费用高于非动脉瘤相关住院。

研究设计与样本

  • ENGAGE PAS研究de novo队列,2011年8月至2012年6月纳入178例,171例(96%)同意经济学分析,177例参与5年生活质量评估。
  • 费用数据直接来自医院账单,按Uniform Billing代码分类;医生费用按CPT代码计算;影像和门诊随访报销按当年Medicare支付率作为费用替代。

主要发现

  • 初始EVAR人均平均住院费用45304美元(IQR 25932-44784美元)。
  • 手术室耗材占总费用50%,人均平均22849美元。
  • 32例患者共37次因额外手术入院,其中14次(38%)为动脉瘤相关;动脉瘤相关后续干预住院中位费用22023美元(IQR 13177-47752美元),非动脉瘤相关中位费用19007美元(IQR 8708-33301美元)。
  • 初始30天访视后,门诊随访影像年人均报销平均550美元(CT 475美元,腹部75美元),办公室访视年人均107美元,合计年人均657美元;EuroQol 5D各维度随访与基线无显著差异。

临床怎么用

  • EVAR费用评估应关注手术室耗材成本,随访再入院多与非动脉瘤原因相关,但动脉瘤相关住院费用更高,需针对性管理。
  • 门诊随访影像和办公室访视的年人均报销657美元可作为EVAR随访经济负担的参考基线。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Trials for endovascular aneurysm repair (EVAR) report lower perioperative mortality and morbidity, but also higher costs compared with open repair. However, few studies have examined the subsequent cost of follow-up evaluations and interventions. Therefore, we present the index and 5-year follow-up costs of EVAR from the Endurant Stent Graft System Post Approval Study. METHODS: From August 2011 to June 2012, 178 patients were enrolled in the Endurant Stent Graft System Post Approval Study de novo cohort and treated with the Medtronic Endurant stent graft system (Medtronic Vascular, Santa Rosa, Calif), of whom 171 (96%) consented for inclusion in the economic analysis and 177 participated in the quality-of-life (QOL) assessment over a 5-year follow-up period. Cost data for the index and follow-up hospitalizations were tabulated directly from hospital bills and categorized by Uniform Billing codes. Surgeon costs were calculated by Current Procedural Terminology codes for each intervention. Current Procedural Terminology codes were also used to calculate imaging and clinic follow-up reimbursement as surrogate to cost based on year-specific Medicare payment rates. Additionally, we compared aneurysm-related versus nonaneurysm-related subsequent hospitalization costs and report EuroQol 5D QOL dimensions. RESULTS: The mean hospital cost per person for the index EVAR was $45,304 (interquartile range [IQR], $25,932-$44,784). The largest contributor to the overall cost was operating room supplies, which accounted for 50% of the total cost at a mean of $22,849 per person. One hundred patients had 233 additional post index admission inpatient admissions; however, only 32 readmissions (14%) were aneurysm related, with a median cost of $13,119 (IQR, $4570-$24,153) compared with a nonaneurysm-related median cost of $6609 (IQR, $1244-$26,466). Additionally, 32 patients were admitted a total of 37 times for additional procedures after index admission, of which 14 (38%) were aneurysm-related. The median cost of hospitalization for aneurysm-related subsequent intervention was $22,023 (IQR, $13,177-$47,752), compared with a median nonaneurysm-related subsequent intervention cost of $19,007 (IQR, $8708-$33,301). After the initial 30-day visit, outpatient follow-up imaging reimbursement averaged $550 per person per year ($475 for computed tomography scans, $75 for the abdomen), whereas annual office visits averaged $107 per person per year, for a total follow-up reimbursement of $657 per person per year. There were no significant differences in the five EuroQol 5D QOL dimensions at each follow-up compared with baseline. CONCLUSIONS: Costs associated with index EVAR are driven primarily by cost of operating room supplies, including graft components. Subsequent admissions are largely not aneurysm related; however, cost of aneurysm-related hospitalizations is higher than for nonaneurysm admissions. These data will serve as a baseline for comparison with open repair and other devices.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Li C, Deery SE, Eisenstein EL, et al. Index and follow-up costs of endovascular abdominal aortic aneurysm repair from the Endurant Stent Graft System Post Approval Study (ENGAGE PAS). J Vasc Surg. 2020. PMID: 31964574. doi:10.1016/j.jvs.2019.11.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。